Campbell & CO Investment Adviser LLC Corcept Therapeutics Inc Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

A detailed history of Campbell & CO Investment Adviser LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 9,292 shares of CORT stock, worth $477,608. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,292
Holding current value
$477,608
% of portfolio
0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$29.51 - $46.26 $274,206 - $429,847
9,292 New
9,292 $429,000
Q4 2023

Feb 13, 2024
BUY
$24.82 - $32.88 $559,641 - $741,378
22,548 Added 224.81%
32,578 $1.06 Million
Q3 2023

Nov 08, 2023
SELL
$21.97 - $33.8 $292,640 - $450,215
-13,320 Reduced 57.04%
10,030 $273,000
Q2 2023

Aug 11, 2023
BUY
$21.44 - $25.15 $83,830 - $98,336
3,910 Added 20.11%
23,350 $519,000
Q1 2023

May 11, 2023
SELL
$19.2 - $24.47 $858,009 - $1.09 Million
-44,688 Reduced 69.69%
19,440 $421,000
Q4 2022

Feb 14, 2023
BUY
$19.95 - $29.96 $542,859 - $815,241
27,211 Added 73.71%
64,128 $1.3 Million
Q3 2022

Nov 14, 2022
BUY
$24.7 - $29.12 $441,512 - $520,520
17,875 Added 93.87%
36,917 $947,000
Q2 2022

Aug 09, 2022
SELL
$17.33 - $25.3 $597,157 - $871,787
-34,458 Reduced 64.41%
19,042 $453,000
Q1 2022

May 09, 2022
BUY
$16.53 - $25.21 $884,355 - $1.35 Million
53,500 New
53,500 $1.21 Million
Q4 2021

Feb 10, 2022
SELL
$17.1 - $23.34 $277,020 - $378,108
-16,200 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$19.68 - $22.53 $30,504 - $34,921
1,550 Added 10.58%
16,200 $319,000
Q2 2021

Aug 11, 2021
BUY
$19.97 - $24.43 $58,911 - $72,068
2,950 Added 25.21%
14,650 $322,000
Q1 2021

May 14, 2021
BUY
$23.49 - $30.56 $274,833 - $357,552
11,700 New
11,700 $278,000
Q4 2020

Feb 09, 2021
SELL
$16.78 - $27.3 $494,791 - $804,995
-29,487 Closed
0 $0
Q3 2020

Oct 15, 2020
BUY
$12.46 - $19.98 $367,408 - $589,150
29,487 New
29,487 $513,000
Q1 2020

Apr 29, 2020
SELL
$10.11 - $14.04 $652,175 - $905,692
-64,508 Closed
0 $0
Q4 2019

Jan 23, 2020
BUY
$12.06 - $16.96 $777,966 - $1.09 Million
64,508 New
64,508 $781,000
Q4 2017

Feb 14, 2018
SELL
$15.77 - $20.72 $367,441 - $482,776
-23,300 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$12.3 - $19.3 $286,590 - $449,690
23,300
23,300 $450,000

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email